Form D · Biotechnology
SOLAZYME INC
South San Francisco, CA · CIK 0001311230
Offering snapshot reported Mar 24, 2016 · SEC filing
- Reported sold
- $28.8M Offering amount: $28.8M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 10, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 24, 2016 | Initial | $28,750,000 | No comparison | 18 | SEC filing |
| Sep 8, 2010 | Amendment | $59,999,825 | $8,449,952vs Aug 9, 2010 | 22 | SEC filing |
| Aug 9, 2010 | Initial | $51,549,873 | No comparison | 17 | SEC filing |
| Mar 16, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 15, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 21, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 26, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 28, 2006 | Paper | Not reported | No comparison | Not reported | |
| Apr 28, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-259885
Source: Form D, filed Mar 24, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael V. Arbige | Director |
| Irene Chang Britt | Director |
| Ian T. Clark | Director |
| James R. Craigie | Director |
| Harrison Dillon | Director, Executive |
| Jerry Fiddler | Director |
| William Lese | Director |
| Peter J. Licari | Executive |
| Daniel H. Miller | Director |
| Tyler W. Painter | Executive |
| Gary M. Pfeiffer | Director |
| Paul T. Quinlan | Executive |
| Jonathan S. Wolfson | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
225 Gateway Blvd.
South San Francisco, CA, 94080
South San Francisco, CA, 94080